Breaking News - The Fly

Open Search

IMRX

Immuneering

$

()

Immuneering presents preclinical data on IMM-1-104 at AACR 2024

IMRX

4/9/2024 - 12:06pm

Immuneering price target lowered by $12 at Mizuho, here's why

IMRX

4/2/2024 - 06:36am

Immuneering announces first patient dosed in Phase 1/2 trial of IMM-6-415

IMRX

3/27/2024 - 08:11am

Immuneering price target lowered by $5 at Needham, here's why

IMRX

3/15/2024 - 09:23am

Immuneering price target lowered by $5 at Chardan, here's why

IMRX

3/15/2024 - 06:49am

Immuneering just downgraded at Jefferies, here's why

IMRX

3/15/2024 - 06:30am

Immuneering just downgraded at TD Cowen, here's why

IMRX

3/14/2024 - 16:14pm

Immuneering just downgraded at Guggenheim, here's why

IMRX

3/14/2024 - 13:19pm

Immuneering Corp trading resumes

IMRX

3/14/2024 - 09:40am

Immuneering Corp trading halted, volatility trading pause

IMRX

3/14/2024 - 09:35am

Immuneering announces near-term milestone expectations

IMRX

3/14/2024 - 07:20am

Immuneering announces results from Phase 1 portion of IMM-1-104 Phase 1/2a trial

IMRX

3/14/2024 - 07:20am

Immuneering appoints Thomas Schall to board of directors

IMRX

3/12/2024 - 08:18am

Immuneering doses first patient in Phase 2a trial of IMM-1-104

IMRX

3/11/2024 - 08:14am

Immuneering announces near-term milestone expectations

IMRX

3/1/2024 - 08:08am